Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
67.14 CAD | -1.29% | -3.55% | +15.44% |
15/05 | Ovintiv Insider Sold Shares Worth $600,000, According to a Recent SEC Filing | MT |
15/05 | Ovintiv Maintained at Buy at UBS Following First-Quarter Results; Price Target Raised to US$70.00 | MT |